Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-13
1999-11-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 141, 424 169, 424 111, 530311, 530317, A61K 3800
Patent
active
059814772
ABSTRACT:
This invention relates to diagnostic and radiodiagnostic agents, including radiolabeled scintigraphic imaging agents, and therapeutic and radiotherapeutic agents. The invention provides such agents and reagents for preparing such agents, and methods for producing and using such reagents. Specifically, the invention provides radiolabeled imaging agents and non-radioactively labeled imaging agents for imaging sites in a mammalian body and reagents for preparing these imaging agents. The invention also provides radiolabeled therapeutic agents, as well as non-radioactively labeled therapeutic agents, and reagents and methods for preparing these agents. The agents and reagents provided comprise a specific binding peptide, covalently linked to a metal ion-complexing moiety. Reagents, methods and kits for making such reagents, methods for labeling such reagents, and methods for using such labeled reagents are provided.
REFERENCES:
patent: 4235886 (1980-11-01), Freidinger
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4611054 (1986-09-01), Freidinger
patent: 4612366 (1986-09-01), Nutt
patent: 4668503 (1987-05-01), Hnatowich
patent: 4732684 (1988-03-01), Tolman
patent: 4832940 (1989-05-01), Ege et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4943523 (1990-07-01), Stavrianopoulous
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 4986979 (1991-01-01), Morgan et al.
patent: 5061641 (1991-10-01), Shochat et al.
patent: 5091514 (1992-02-01), Fritzberg et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5112953 (1992-05-01), Gustavson et al.
patent: 5175257 (1992-12-01), Kasina et al.
patent: 5180816 (1993-01-01), Dean et al.
patent: 5196515 (1993-03-01), Lever et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5248764 (1993-09-01), Flanagan et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5405597 (1995-04-01), Dean et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5620675 (1997-04-01), McBride et al.
patent: 5632969 (1997-05-01), Flanagan et al.
Rhodes, 1974, "Considerations in the Radiolabeling of Albumin", Sem. Nucl. Med. 4: 281-293.
Davidson et al., 1981, "A New Class of Oxotechnetium(5+) Chelate Complexes containing a TcON.sub.2 S.sub.2 Core", Inorg. Chem. 20:1629-16.
Fritzberg et al., 1982, "Synthesis anbd Biological Evaluation of Tc-99m N,N'-Bis(mercaptoacetyl)-2,3-diaminopropanoate: A Potential Replacement for [.sup.131 I]o-iodohippurate", J. Nucl. Med. 23:592-598.
Khaw et al., 1982, "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen", J. Nucl. Med. 23: 1011-1019.
Byrne and Tolman, 1983, "Technetium-99m Bifunctional Chelating Agent--Thiolactone for Coupling to Biomolecules, N.sub.2 S.sub.2 Ligand for Chelation to Technetium", J. Nucl. Med. 24: P126.
Bryson et al., 1988, "Neutral Technetium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands", Inorg. Chem. 27:2154-2161.
Misra et al., 1989, "Synthesis of a Novel Diaminodithiol Ligand for Labeling Proteins and Small Molecules with Technetium-99m", Tet. Lett. 30: 1885-1888.
Bryson et al., 1990, "Protecting Groups inb the Preparation of Thiolate Complexes of Technetium", Inorg. Chem. 29:2948-2951.
Knight et al., 1990, "Thrombus Imaging with Tc-99m Synthetic peptides Reactive with Activated Platelets", J. Nucl. Med. 31: 757 #209.
Bakker et al., 1990, "Receptor Scintigraphy with a Radioiodinated Somatostatin Analogue: Radiolabeling, Purification, Biologic Activity, and In Vivo Application in Animals", J. Nucl. Med. 31: 1501-1509.
Bakker et al., 1991, "In Vivo Use of a Radioiodinated Somatostatin Analogue: Dynamics, Metabolism, and Binding to Somatostatin Receptor-Positive Tumors in Man", J. Nucl. Med. 32: 1184-1189.
Kwekkeboom et al., 1991, "[In-111-DTPA-D-Phe].sup.1 -Octreotide Scintigraphy in Neuro-endocrine Tumors", J. Nucl. Med. 32: 981, Abstract #305.
Pearson et al., (1996) "Somatostat Receptor-Binding Peptides Labeled With Technetium-99M: Chemistry And initial Biological Studies." J. Med. Chem., vol. 39, No. 7, pp. 1361-1371.
Faglia et al., 1991, "In Vivo Detection of Somatostatin Receptors in Patients with Functionless Pituitary Adenomas by Means of a Radioiodinated Analog of Somatostatin ([.sup.123 I]-SDZ 204-090)", J. Clin. Endocrinol. Metab. 73: 850-856.
Albert et al., 1991, "A Somatostatin Ananlogue to Image SS-Receptor-Positive Tumors: [.sup.111 In-DTPA-DPhe].sup.1 -Octreotide (SDZ 215-811)", Abstract LM10, 12th Amer. Peptide Symposium.
Cox et al., 1991, "Technetium Labeled Somatostatin: A Potential Agent for In Vivo Tumor Localization", Abstract, 7th International Symposium on Radiopharmacology, p. 16.
Schwartz et al., 1991, "Preparation of Hydrazino-Modified Proteins and Their Use for the Synthesis of .sup.99m Tc-Protein Conjugates", Bioconjugate Chem. 2: 333.
Krenning et al., 1992, "Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dositometry and Comparison with Iodine-123-Tyr-3-Octreotide", J. Nucl. Med. 33: 652-658.
Bomanji et al., 1992, "A Scintigraphic Comparison of Iodine-123-Metaiodobenzylguanidine and an Iodine-Labeled Somatostatin Analog (Tyr-3-Octreotide) in Metastatic Carcinoid Tumors", J. Nucl. Med. 33: 1121-1124.
Babich et al., 1993, "Technetium-99m-Labeled Hydrazino Nicotinamide Derivatized Chemotactic Peptide Analogs for Imaging Focal Sites of Bacterial Infection", J. Nucl. Med. 34: 1964-1974.
Diatide, Inc.
McDaniels Patricia A.
Noonan Kevin E.
Tsang Cecilia J.
LandOfFree
Peptide-metal chelate conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide-metal chelate conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-metal chelate conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455952